The global nucleic acid labeling market size surpassed USD 2,480 million in 2024 and is predicted to reach around USD 5,060 million by 2034, registering a CAGR of 7.4% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 2,660 Million |
| Market Size by 2034 | USD 5,060 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 7.4% |
Nucleic acid labeling refers to attaching labels to DNA or RNA that enable their detection and/or purification. Such labels can then be utilized to study, interact with, or recover other molecules. Furthermore, it also helps in measuring the quantity and presence of specific DNA or RNA sequences.
The increasing application of nucleic acid-based diagnostics across various healthcare domains drives market growth worldwide. Furthermore, opportunities are thriving in the market with the expansion of application areas into cancer research, agriculture biotechnology, and the field of genomics. The nucleic acid labeling market is growing with incentives and investments by the government in research and development of the biopharmaceutical market.
"Isolating viral nucleic acids is crucial for several areas of life sciences research, including viral genome sequencing, infectious disease detection, and wastewater surveillance. These methods require high sensitivity to detect the canonically low amount of virus in a sample, and high throughput to meet the demands of infectious disease testing and surveillance."
“By eliminating stutter artifacts, an analyst can more accurately identify low-level contributors and better determine the number of contributors in highly complex mixtures,”
Artificial Intelligence (AI) contributes immensely towards streamlining business operations through machine learning and automation.
North America
North America dominates the nucleic acid labeling market in 2024 with the largest market share. The presence of leading global players and a high increase in investment for research and development in the biotechnology market drive the growth of the nucleic acid labeling market. The region experiences utilization of nucleic acid labeling in sequencing, gene expression analysis, labeling kits, and PCR. The adoption of nucleic acid labeling technologies with advanced research facilities for molecular diagnostics and personalized medicine also contributes to the market growth.
Europe
Europe is expected to experience the fastest growth in the forecasted period of 2025-2034. Europe is the second largest contributor in the market share, and the region boasts biotechnology and pharmaceutical companies with extensive investment in research and development in biopharmaceuticals, including academic collaborations and government funding in healthcare, which drive the market growth of the nucleic acid labeling market.
APAC
The Asia-Pacific region is growing rapidly in the nucleic acid labeling market in the forecasted period of 2025-2034. The region is experiencing an increase in research and development on genomics, with governments aiding with incentives and investment in the healthcare sector to boost market growth.
The nuclear acid labeling market is highly competitive with big players all over the globe. The leading companies in the market include Thermo Fisher Scientific, Merck KGaA, F. Hoffmann-La Roche Ltd, PerkinElmer, GE Healthcare, Promega Corporation, and New England Biolabs, which hold the major market share.
The market is dominated by several companies, but the companies that are renowned for their contribution in the market are listed below:
Thermo Fisher Scientific was established by a merger between Thermo Electron and Fisher Scientific. It provides many kinds of products and services throughout 600+ locations across America, APAC, and EMEA regions.
Merck achieved substantial growth, with an annual revenue of $ 64 billion in the year 2024, with a fair increase from the previous year, and is expected to grow at the same rate in the forecasted period.
F. Hoffmann-La Roche Ltd is a leading global Swiss healthcare company with expertise in the field of pharmaceuticals and diagnostics. The company is known worldwide for its extensive research for prevention, treatment, and diagnosis of chronic diseases.
Published by Ajit Bansod
